Global Stomach Cancer and Gastric Cancer Drugs Market Size, Status and Forecast 2024-2031

Report ID: 922420 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors
        1.2.3 Human Epidermal Growth Factor Receptor (HER2) Antagonists
        1.2.4 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Perspective (2016-2027)
    2.2 Stomach Cancer and Gastric Cancer Drugs Growth Trends by Regions
        2.2.1 Stomach Cancer and Gastric Cancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Stomach Cancer and Gastric Cancer Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Stomach Cancer and Gastric Cancer Drugs Industry Dynamic
        2.3.1 Stomach Cancer and Gastric Cancer Drugs Market Trends
        2.3.2 Stomach Cancer and Gastric Cancer Drugs Market Drivers
        2.3.3 Stomach Cancer and Gastric Cancer Drugs Market Challenges
        2.3.4 Stomach Cancer and Gastric Cancer Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Stomach Cancer and Gastric Cancer Drugs Players by Revenue
        3.1.1 Global Top Stomach Cancer and Gastric Cancer Drugs Players by Revenue (2016-2021)
        3.1.2 Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Stomach Cancer and Gastric Cancer Drugs Revenue
    3.4 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio
        3.4.1 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer and Gastric Cancer Drugs Revenue in 2020
    3.5 Stomach Cancer and Gastric Cancer Drugs Key Players Head office and Area Served
    3.6 Key Players Stomach Cancer and Gastric Cancer Drugs Product Solution and Service
    3.7 Date of Enter into Stomach Cancer and Gastric Cancer Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Type
    4.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2022-2027)

5 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Application
    5.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size (2016-2027)
    6.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type
        6.2.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021)
        6.2.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027)
        6.2.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2027)
    6.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application
        6.3.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021)
        6.3.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027)
        6.3.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2027)
    6.4 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country
        6.4.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021)
        6.4.2 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size (2016-2027)
    7.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type
        7.2.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2027)
    7.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application
        7.3.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2027)
    7.4 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country
        7.4.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type
        8.2.1 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application
        8.3.1 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region
        8.4.1 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size (2016-2027)
    9.2 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type
        9.2.1 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2027)
    9.3 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application
        9.3.1 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2027)
    9.4 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country
        9.4.1 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type
        10.2.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application
        10.3.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country
        10.4.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Ipsen Pharma
        11.1.1 Ipsen Pharma Company Details
        11.1.2 Ipsen Pharma Business Overview
        11.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Introduction
        11.1.4 Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.1.5 Ipsen Pharma Recent Development
    11.2 Merck & Co., Inc.
        11.2.1 Merck & Co., Inc. Company Details
        11.2.2 Merck & Co., Inc. Business Overview
        11.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Introduction
        11.2.4 Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.2.5 Merck & Co., Inc. Recent Development
    11.3 Bristol-Myers Squibb Company
        11.3.1 Bristol-Myers Squibb Company Company Details
        11.3.2 Bristol-Myers Squibb Company Business Overview
        11.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Introduction
        11.3.4 Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.3.5 Bristol-Myers Squibb Company Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Details
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Introduction
        11.4.4 Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.4.5 Eli Lilly Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Introduction
        11.5.4 Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 Novartis AG
        11.6.1 Novartis AG Company Details
        11.6.2 Novartis AG Business Overview
        11.6.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Introduction
        11.6.4 Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.6.5 Novartis AG Recent Development
    11.7 Bayer AG
        11.7.1 Bayer AG Company Details
        11.7.2 Bayer AG Business Overview
        11.7.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Introduction
        11.7.4 Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.7.5 Bayer AG Recent Development
    11.8 Celltrion Inc.
        11.8.1 Celltrion Inc. Company Details
        11.8.2 Celltrion Inc. Business Overview
        11.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Introduction
        11.8.4 Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.8.5 Celltrion Inc. Recent Development
    11.9 TAIHO PHARMACEUTICAL CO., LTD.
        11.9.1 TAIHO PHARMACEUTICAL CO., LTD. Company Details
        11.9.2 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
        11.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Introduction
        11.9.4 TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Development
    11.10 Jiangsu Hengrui Medicine Co., Ltd.
        11.10.1 Jiangsu Hengrui Medicine Co., Ltd. Company Details
        11.10.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
        11.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Introduction
        11.10.4 Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
        11.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Programmed Cell Death Protein 1 (PD-1) Inhibitors
    Table 3. Key Players of Human Epidermal Growth Factor Receptor (HER2) Antagonists
    Table 4. Key Players of Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
    Table 5. Key Players of Others
    Table 6. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Regions (2016-2021)
    Table 10. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Regions (2022-2027)
    Table 12. Stomach Cancer and Gastric Cancer Drugs Market Trends
    Table 13. Stomach Cancer and Gastric Cancer Drugs Market Drivers
    Table 14. Stomach Cancer and Gastric Cancer Drugs Market Challenges
    Table 15. Stomach Cancer and Gastric Cancer Drugs Market Restraints
    Table 16. Global Stomach Cancer and Gastric Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Players (2016-2021)
    Table 18. Global Top Stomach Cancer and Gastric Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2020)
    Table 19. Ranking of Global Top Stomach Cancer and Gastric Cancer Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Stomach Cancer and Gastric Cancer Drugs Product Solution and Service
    Table 23. Date of Enter into Stomach Cancer and Gastric Cancer Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Stomach Cancer and Gastric Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Ipsen Pharma Company Details
    Table 64. Ipsen Pharma Business Overview
    Table 65. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product
    Table 66. Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 67. Ipsen Pharma Recent Development
    Table 68. Merck & Co., Inc. Company Details
    Table 69. Merck & Co., Inc. Business Overview
    Table 70. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product
    Table 71. Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 72. Merck & Co., Inc. Recent Development
    Table 73. Bristol-Myers Squibb Company Company Details
    Table 74. Bristol-Myers Squibb Company Business Overview
    Table 75. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product
    Table 76. Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 77. Bristol-Myers Squibb Company Recent Development
    Table 78. Eli Lilly Company Details
    Table 79. Eli Lilly Business Overview
    Table 80. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product
    Table 81. Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 82. Eli Lilly Recent Development
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Stomach Cancer and Gastric Cancer Drugs Product
    Table 86. Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 87. Roche Recent Development
    Table 88. Novartis AG Company Details
    Table 89. Novartis AG Business Overview
    Table 90. Novartis AG Stomach Cancer and Gastric Cancer Drugs Product
    Table 91. Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 92. Novartis AG Recent Development
    Table 93. Bayer AG Company Details
    Table 94. Bayer AG Business Overview
    Table 95. Bayer AG Stomach Cancer and Gastric Cancer Drugs Product
    Table 96. Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 97. Bayer AG Recent Development
    Table 98. Celltrion Inc. Company Details
    Table 99. Celltrion Inc. Business Overview
    Table 100. Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 101. Celltrion Inc. Recent Development
    Table 102. TAIHO PHARMACEUTICAL CO., LTD. Company Details
    Table 103. TAIHO PHARMACEUTICAL CO., LTD. Business Overview
    Table 104. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product
    Table 105. TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 106. TAIHO PHARMACEUTICAL CO., LTD. Recent Development
    Table 107. Jiangsu Hengrui Medicine Co., Ltd. Company Details
    Table 108. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
    Table 109. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product
    Table 110. Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021) & (US$ Million)
    Table 111. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Programmed Cell Death Protein 1 (PD-1) Inhibitors Features
    Figure 3. Human Epidermal Growth Factor Receptor (HER2) Antagonists Features
    Figure 4. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Features
    Figure 5. Others Features
    Figure 6. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Stomach Cancer and Gastric Cancer Drugs Report Years Considered
    Figure 10. Global Stomach Cancer and Gastric Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Stomach Cancer and Gastric Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Regions: 2020 VS 2027
    Figure 13. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Regions (2022-2027)
    Figure 14. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Players in 2020
    Figure 15. Global Top Stomach Cancer and Gastric Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue in 2020
    Figure 17. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2016-2021)
    Figure 18. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2022-2027)
    Figure 19. North America Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2016-2027)
    Figure 21. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2016-2027)
    Figure 22. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2016-2027)
    Figure 23. United States Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2016-2027)
    Figure 27. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2016-2027)
    Figure 28. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2016-2027)
    Figure 29. Germany Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2016-2027)
    Figure 39. China Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2016-2027)
    Figure 47. Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2016-2027)
    Figure 48. Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2016-2027)
    Figure 49. Mexico Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2016-2027)
    Figure 55. Turkey Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Ipsen Pharma Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 59. Merck & Co., Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 61. Eli Lilly Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 63. Novartis AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 64. Bayer AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 65. Celltrion Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 66. TAIHO PHARMACEUTICAL CO., LTD. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 67. Jiangsu Hengrui Medicine Co., Ltd. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ipsen Pharma
Merck & Co., Inc.
Bristol-Myers Squibb Company
Eli Lilly
Roche
Novartis AG
Bayer AG
Celltrion Inc.
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.
Frequently Asked Questions
Stomach Cancer and Gastric Cancer Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Stomach Cancer and Gastric Cancer Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Stomach Cancer and Gastric Cancer Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hepatitis B Drug

Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medicatio ... Read More